Epstein Secrets

gn such talks were imminent." The New York Times <https://www.nytimes.com/2020/11/12/business/economy/economy-covid-stimulus.html> (11/12, Smialek, Cochrane, Fandos, Rappeport, 18.61M) says "in holding firm to their respective positions — Democrats demanding $2.4 trillion as a starting point, with Republi

ters <https://www.reuters.corn/article/us-health-coronavirus-fatality/covid-19-fatality-rate-down-30-since- april-study-finds-idUSICBN27S39D> (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

s remain. Meanwhile, the New York Times <https://www.nytimes.corn/2020/08/03/us/politics/congress-jobless-aid-talks- trump.html> (8/3, A1, Haberman, Cochrane, Tankersley, 18.61M) reports under the headline "With Jobless Aid Expired, Trump Sidelines Himself In Stimulus Talks," as his "top advisers met with

s://www.reuters.com/article/us-health-coronavirus-treatments-antibod/next-big-covid-19-treatment-may-be- manufactured-antibodies-idUSKBN2421DY> (8/3, Beasley) reports, "As the world awaits a COVID-I9 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

y shield for employers." The New York Times <https://vvww.nytimes.com/2020/10/22/business/stimulus-deal-may-wait-until-after- election.html> (10/22, Cochrane, Broadwater, 18.61 M) says Pelosi "was noncommittal on Thursday about bringing a stimulus measure to the House floor for a vote before the November

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

avirus relief package to McConnell and Pelosi for the time being," there is "no sign such talks were imminent." The New York Times (11/12, Smialek, Cochrane, Fandos, Rappeport, 18.61M) says "in holding firm to their respective positions - Democrats demanding $2.4 trillion as a starting point, with Repub

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

s for aid to state and local governments, school funding and Republican insistence on a liability shield for employers." The New York Times (10/22, Cochrane, Broadwater, 18.61M) says Pelosi "was noncommittal on Thursday about bringing a stimulus measure to the House floor for a vote before the November

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

avirus relief package to McConnell and Pelosi for the time being," there is "no sign such talks were imminent." The New York Times (11/12, Smialek, Cochrane, Fandos, Rappeport, 18.61M) says "in holding firm to their respective positions - Democrats demanding $2.4 trillion as a starting point, with Repub

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

s for aid to state and local governments, school funding and Republican insistence on a liability shield for employers." The New Ynrk TIMPc (10/22, Cochrane, Broadwater, 18.61M) says Pelosi "was noncommittal on Thursday about bringing a stimulus measure to the House floor for a vote before the November

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

ation, 7.57M) says both sides expressed cautious optimism, though significant differences remain. Meanwhile, the New York Times (8/3, Al, Haberman, Cochrane, Tankersley, 18.61M) reports under the headline "With Jobless Aid Expired, Trump Sidelines Himself In Stimulus Talks," as his "top advisers met wit

RN- TVVi Nashville, TN (8/3, 24K), and WXIA-TVVI Atlanta (8/3, 100K). Monoclonal Antibodies Could Be "Next Big Advance" In Treatment. Reuters (8/3, Beasley) reports, "As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

ation, 7.57M) says both sides expressed cautious optimism, though significant differences remain. Meanwhile, the New York Times (8/3, Al, Haberman, Cochrane, Tankersley, 18.61M) reports under the headline "With Jobless Aid Expired, Trump Sidelines Himself In Stimulus Talks," as his "top advisers met wit

RN- TVVi Nashville, TN (8/3, 24K), and WXIA-TVVI Atlanta (8/3, 100K). Monoclonal Antibodies Could Be "Next Big Advance" In Treatment. Reuters (8/3, Beasley) reports, "As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically